We previously demonstrated its anti-osteoarthritic effects in IL-1β-stimulated human chondrocytes and in a rat model of monosodium iodoacetate–induced osteoarthritis, showing significant reductions in cartilage degradation and inflammatory markers. This evidence concerns the gene IL1B and osteoarthritis.